Relationship between coronary blood flow and improvement of cardiac function after catheter ablation for persistent atrial fibrillation

Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001;37:371–8. https://doi.org/10.1016/s0735-1097(00)01107-4.

Article  CAS  PubMed  Google Scholar 

Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837–47. https://doi.org/10.1161/CIRCULATIONAHA.113.005119.

Article  PubMed  Google Scholar 

Lévy S, Steinbeck G, Santini L, Nabauer M, Maceda DP, Kantharia BK, Saksena S, Cappato R. Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society. J Interv Card Electrophysiol. 2022;65(1):287–326. https://doi.org/10.1007/s10840-022-01195-z.

Article  PubMed  Google Scholar 

Verhaert DVM, Brunner-La Rocca HP, van Veldhuisen DJ, Vernooy K. The bidirectional interaction between atrial fibrillation and heart failure: consequences for the management of both diseases. Europace. 2021;23(Suppl 2):ii40-5. https://doi.org/10.1093/europace/euaa368.

Article  PubMed  PubMed Central  Google Scholar 

Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bänsch D, CASTLE-AF Investigators. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417–27. https://doi.org/10.1056/NEJMoa1707855.

Article  PubMed  Google Scholar 

Prabhu S, Taylor AJ, Costello BT, Kaye DM, McLellan AJA, Voskoboinik A, Sugumar H, Lockwood SM, Stokes MB, Pathik B, Nalliah CJ, Wong GR, Azzopardi SM, Gutman SJ, Lee G, Layland J, Mariani JA, Ling LH, Kalman JM, Kistler PM. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol. 2017;70:1949–61. https://doi.org/10.1016/j.jacc.2017.08.041.

Article  PubMed  Google Scholar 

Packer DL, Piccini JP, Monahan KH, Al-Khalidi HR, Silverstein AP, Noseworthy PA, Poole JE, Bahnson TD, Lee KL, Mark DB, CABANA Investigators. Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial. Circulation. 2021;143:1377–90. https://doi.org/10.1161/CIRCULATIONAHA.120.050991.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hunter RJ, Berriman TJ, Diab I, Kamdar R, Richmond L, Baker V, Goromonzi F, Sawhney V, Duncan E, Page SP, Ullah W, Unsworth B, Mayet J, Dhinoja M, Earley MJ, Sporton S, Schilling RJ. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014;7:31–8. https://doi.org/10.1161/CIRCEP.113.000806.

Article  CAS  PubMed  Google Scholar 

Luo C, Wu X, Huang Z, Du Z, Hao Y, Hu C, Huang Y, Gao X. Documentation of impaired coronary blood flow by TIMI frame count method in patients with atrial fibrillation. Int J Cardiol. 2013;167:1176–80. https://doi.org/10.1016/j.ijcard.2012.03.118.

Article  PubMed  Google Scholar 

KemaloğluÖz T, Eren M, Atasoy I, Gürol T, Soylu Ö, Dağdeviren B. Are biventricular systolic functions impaired in patient with coronoray slow flow? A prospective study with three dimensional speckle tracking. Int J Cardiovasc Imaging. 2017;33:675–81. https://doi.org/10.1007/s10554-016-1054-2.

Article  Google Scholar 

Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93:879–88. https://doi.org/10.1161/01.CIR.93.5.879.

Article  CAS  PubMed  Google Scholar 

Range FT, Paul M, Schäfers KP, Acil T, Kies P, Hermann S, Schober O, Breithardt G, Wichter T, Schäfers MA. Myocardial perfusion in nonischemic dilated cardiomyopathy with and without atrial fibrillation. J Nucl Med. 2009;50:390–6. https://doi.org/10.2967/jnumed.108.055665.

Article  PubMed  Google Scholar 

Qin D, Mansour MC, Ruskin JN, Heist EK. Atrial fibrillation-mediated cardiomyopathy. Circ Arrhythm Electrophysiol. 2019;12:e007809. https://doi.org/10.1161/CIRCEP.119.007809.

Article  PubMed  Google Scholar 

Martin CA, Lambiase PD. Pathophysiology, diagnosis and treatment of tachycardiomyopathy. Heart. 2017;103:1543–52. https://doi.org/10.1136/heartjnl-2016-310391.

Article  PubMed  Google Scholar 

Range FT, Schäfers M, Acil T, Schäfers KP, Kies P, Paul M, Hermann S, Brisse B, Breithardt G, Schober O, Wichter T. Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation. Eur Heart J. 2007;28:2223–30. https://doi.org/10.1093/eurheartj/ehm246.

Article  PubMed  Google Scholar 

Askew JW, Miller TD, Hodge DO, Gibbons RJ. The value of myocardial perfusion single-photon emission computed tomography in screening asymptomatic patients with atrial fibrillation for coronary artery disease. J Am Coll Cardiol. 2007;50:1080–5. https://doi.org/10.1016/j.jacc.2007.05.035.

Article  PubMed  Google Scholar 

Smit MD, Tio RA, Slart RH, Zijlstra F, Van Gelder IC. Myocardial perfusion imaging does not adequately assess the risk of coronary artery disease in patients with atrial fibrillation. Europace. 2010;12:643–8.

Article  PubMed  Google Scholar 

Gimelli A, Liga R, Startari U, Giorgetti A, Pieraccini L, Marzullo P. Evaluation of ischaemia in patients with atrial fibrillation: impact of stress protocol on myocardial perfusion imaging accuracy. Eur Heart J Cardiovasc Imaging. 2015;16:781–7. https://doi.org/10.1093/ehjci/jeu322.

Article  PubMed  Google Scholar 

Jeong YH, Choi KJ, Song JM, Hwang ES, Park KM, Nam GB, Kim JJ, Kim YH. Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy. Clin Cardiol. 2008;31:172–8. https://doi.org/10.1002/clc.20161.

Article  PubMed  PubMed Central  Google Scholar 

Sohns C, Zintl K, Zhao Y, Dagher L, Andresen D, Siebels J, Wegscheider K, Sehner S, Boersma L, Merkely B, Pokushalov E, Sanders P, Schunkert H, Bänsch D, Mahnkopf C, Brachmann J, Marrouche NF. Impact of left ventricular function and heart failure symptoms on outcomes post ablation of atrial fibrillation in heart failure: CASTLE-AF trial. Circ Arrhythm Electrophysiol. 2020;13:e008461. https://doi.org/10.1161/CIRCEP.120.008461.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif